216 related articles for article (PubMed ID: 24088534)
1. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study).
Richardus RA; Alam K; Pahan D; Feenstra SG; Geluk A; Richardus JH
BMC Infect Dis; 2013 Oct; 13():456. PubMed ID: 24088534
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.
Richardus R; Alam K; Kundu K; Chandra Roy J; Zafar T; Chowdhury AS; Nieboer D; Faber R; Butlin CR; Geluk A; Richardus JH
Int J Infect Dis; 2019 Nov; 88():65-72. PubMed ID: 31499206
[TBL] [Abstract][Full Text] [Related]
3. Protecting people against leprosy: chemoprophylaxis and immunoprophylaxis.
Richardus JH; Oskam L
Clin Dermatol; 2015; 33(1):19-25. PubMed ID: 25432807
[TBL] [Abstract][Full Text] [Related]
4. Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial.
Dos Santos DS; Duppre NC; Sarno EN; Pinheiro RO; Sales AM; Nery JADC; Moraes MO; Camacho LAB
Trials; 2018 Apr; 19(1):244. PubMed ID: 29685164
[TBL] [Abstract][Full Text] [Related]
5. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
Schoenmakers A; Mieras L; Budiawan T; van Brakel WH
Res Rep Trop Med; 2020; 11():97-117. PubMed ID: 33117053
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials.
Tawfik GM; Biala M; Yousef YM; Tiwari R; Dobs M; Lotfy CI; Farrag DA; Hue AT; Yotsu RR; Huy NT
Clin Microbiol Infect; 2021 Dec; 27(12):1754-1761. PubMed ID: 34332107
[TBL] [Abstract][Full Text] [Related]
7. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh.
Feenstra SG; Pahan D; Moet FJ; Oskam L; Richardus JH
Lepr Rev; 2012 Sep; 83(3):292-304. PubMed ID: 23356030
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh.
Richardus RA; Butlin CR; Alam K; Kundu K; Geluk A; Richardus JH
Vaccine; 2015 Mar; 33(13):1562-7. PubMed ID: 25701674
[TBL] [Abstract][Full Text] [Related]
9. Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.
Younoussa A; Samidine SN; Bergeman AT; Piubello A; Attoumani N; Grillone SH; Braet SM; Tsoumanis A; Baco A; Mzembaba A; Salim Z; Amidy M; Grillone S; Snijders R; Corstjens P; Ortuno-Gutierrez N; Hoof C; Geluk A; de Jong BC; Hasker E
BMC Infect Dis; 2023 May; 23(1):310. PubMed ID: 37161571
[TBL] [Abstract][Full Text] [Related]
10. BCG and Adverse Events in the Context of Leprosy.
Richardus R; van Hooij A; van den Eeden SJF; Wilson L; Alam K; Richardus JH; Geluk A
Front Immunol; 2018; 9():629. PubMed ID: 29670618
[TBL] [Abstract][Full Text] [Related]
11. Role of contact tracing and prevention strategies in the interruption of leprosy transmission.
Smith WC; Aerts A
Lepr Rev; 2014 Mar; 85(1):2-17. PubMed ID: 24974438
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.
Idema WJ; Majer IM; Pahan D; Oskam L; Polinder S; Richardus JH
PLoS Negl Trop Dis; 2010 Nov; 4(11):e874. PubMed ID: 21072235
[TBL] [Abstract][Full Text] [Related]
13. The long-term effect of current and new interventions on the new case detection of leprosy: a modeling study.
Fischer EA; de Vlas SJ; Habbema JD; Richardus JH
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1330. PubMed ID: 21949895
[TBL] [Abstract][Full Text] [Related]
14. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.
Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A
Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818
[TBL] [Abstract][Full Text] [Related]
15. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP.
Moet FJ; Oskam L; Faber R; Pahan D; Richardus JH
Lepr Rev; 2004 Dec; 75(4):376-88. PubMed ID: 15682975
[TBL] [Abstract][Full Text] [Related]
16. Chemoprophylaxis against leprosy: expectations and methodology of a trial.
Vijayakumaran P; Krishnamurthy P; Rao P; Declerq E
Lepr Rev; 2000 Dec; 71 Suppl():S37-40; discussion S40-1. PubMed ID: 11201885
[TBL] [Abstract][Full Text] [Related]
17. BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.
van Hooij A; van den Eeden SJF; Khatun M; Soren S; Franken KLMC; Chandra Roy J; Alam K; Chowdhury AS; Richardus JH; Geluk A
Vaccine; 2021 Dec; 39(50):7230-7237. PubMed ID: 34688497
[TBL] [Abstract][Full Text] [Related]
18. The PEP++ study protocol: a cluster-randomised controlled trial on the effectiveness of an enhanced regimen of post-exposure prophylaxis for close contacts of persons affected by leprosy to prevent disease transmission.
Hinders DC; Taal AT; Lisam S; da Rocha AM; Banstola NL; Bhandari P; Saha A; Kishore J; Fernandes VO; Chowdhury AS; van 't Noordende AT; Mieras L; Richardus JH; van Brakel WH
BMC Infect Dis; 2024 Feb; 24(1):226. PubMed ID: 38378497
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antiphenolic glycolipid-1 antibody levels in seropositive contacts of leprosy after 2 years of single-dose rifampicin as postexposure prophylaxis.
Jusuf Fantoni OJ; Rusmawardiana ; Yahya YF; Bahar E; Toruan TL; Hari Purwoko MI
Int J Mycobacteriol; 2023; 12(4):399-406. PubMed ID: 38149534
[TBL] [Abstract][Full Text] [Related]
20. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
Lancet; 1996 Jul; 348(9019):17-24. PubMed ID: 8691924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
